Wu PV, Rangaswami A (2022) Current Approaches in Hepatoblastoma—New Biological Insights to Inform Therapy [J]. Curr Oncol Rep 24(9):1209–1218
Article CAS PubMed Google Scholar
Meyers RL, Maibach R, Hiyama E et al (2017) Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children’s Hepatic tumors International Collaboration [J]. Lancet Oncol 18(1):122–131
Hubbard AK, Spector LG, Fortuna G et al (2019) Trends in international incidence of pediatric cancers in children under 5 years of age 1988–2012 [J]. JNCI Cancer Spect. 3(1):007
Feusner J, Buckley J, Robison L et al (1998) Prematurity and hepatoblastoma: more than just an association? [J]. J Pediatr 133(4):585–586
Article CAS PubMed Google Scholar
Katzenstein HM, Langham MR, Malogolowkin MH et al (2019) Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children’s Oncology Group, multicentre, phase 3 trial [J]. Lancet Oncol 20(5):719–727
Article PubMed PubMed Central Google Scholar
Angelico R, Grimaldi C, Gazia C et al (2019) How do synchronous lung metastases influence the surgical management of children with hepatoblastoma? An update and systematic review of the literature [J]. Cancers 11(11):1693
Article PubMed PubMed Central Google Scholar
O’Neill AF, Towbin AJ, Krailo MD et al (2017) Characterization of pulmonary metastases in children with hepatoblastoma treated on Children’s Oncology Group Protocol AHEP0731 (the treatment of children with all stages of hepatoblastoma): a report from the Children’s Oncology Group [J]. J Clin Oncol 35(30):3465
Article PubMed PubMed Central Google Scholar
Schnater JM, Köhler SE, Lamers WH et al (2003) Where do we stand with hepatoblastoma? A review [J]. Cancer: Interdis Int J Am Cancer Soc. 98(4):668–678
Agarwala S, Gupta A, Bansal D et al (2017) Management of hepatoblastoma: ICMR consensus document [J]. Indian J Pediatr 84:456–464
Czauderna P, Haeberle B, Hiyama E et al (2016) The Children’s Hepatic tumors International Collaboration (CHIC): novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model [J]. Eur J Cancer 52:92–101
Liang W, Zhang L, Jiang G et al (2015) Development and validation of a nomogram for predicting survival in patients with resected non–small-cell lung cancer [J]. J Clin Oncol 33(8):861–869
Zhou W, Huang C, Yuan N (2018) Prognostic nomograms based on log odds of positive lymph nodes for patients with renal cell carcinoma: a retrospective cohort study [J]. Int J Sur 60:28–40
El Sharouni M-A, Ahmed T, Varey AH et al (2021) Development and validation of nomograms to predict local, regional, and distant recurrence in patients with thin (T1) melanomas [J]. J Clin Oncol 39(11):1243–1252
Chen W, Zhang L, Zhang B et al (2024) Development and validation of nomogram-based models for personalized survival assessment in pediatric hepatoblastoma patients [J]. Trans Cancer Res 13(2):699
Ge B, Zhuo C, Tang Q et al (2023) Clinical features and a prognostic nomogram based on the SEER database for hepatoblastoma, hepatocellular carcinoma, and embryonal sarcoma among children and adolescents [J]. Trans Pediatr 12(2):172
Feng J, Polychronidis G, Heger U et al (2019) Incidence trends and survival prediction of hepatoblastoma in children: a population-based study [J]. Cancer Commun 39:1–9
Wang S, Fu S, Li R et al (2024) Construction and validation of nomogram prognostic model for predicting survival in hepatoblastoma patients: a population-based study [J]. Updates Sur. 2024:1–12
Haeberle B, Rangaswami A, Krailo M et al (2020) The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children’s Hepatic tumors International Collaboration (CHIC) database [J]. Pediatr Blood Cancer 67(8):e28350
Zhi T et al (2021) A new risk-stratification system for hepatoblastoma in children under six years old and the significance for prognosis evaluation-a 14-year retrospective study from a single center [J]. BMC Cancer 21(1):397
Article PubMed PubMed Central Google Scholar
Feng J, He Y, Wei L et al (2019) Assessment of survival of pediatric patients with hepatoblastoma who received chemotherapy following liver transplant or liver resection. JAMA Netw Open 2(10):e1912676. https://doi.org/10.1001/jamanetworkopen
Article PubMed PubMed Central Google Scholar
Aronson DC, Weeda VB, Maibach R et al (2019) Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report [J]. Eur J Cancer 106:126–132
Fonseca A, Gupta A, Shaikh F et al (2018) Extreme hepatic resections for the treatment of advanced hepatoblastoma: are planned close margins an acceptable approach? [J]. Pediatr Blood Cancer 65(2):e26820
Lautz TB, Ben-Ami T, Tantemsapya N et al (2011) Successful nontransplant resection of POST-TEXT III and IV hepatoblastoma [J]. Cancer 117(9):1976–1983
Fuchs J, Cavdar S, Blumenstock G et al (2017) POST-TEXT III and IV hepatoblastoma: extended hepatic resection avoids liver transplantation in selected cases [J]. Ann Sur 266(2):318–323
Otte J-B, Pritchard J, Aronson D et al (2004) Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience [J]. Pediatr Blood Cancer 42(1):74–83
Article CAS PubMed Google Scholar
Kasahara M, Ueda M, Haga H et al (2005) Living-donor liver transplantation for hepatoblastoma [J]. Am J Trans 5(9):2229–2235
Comments (0)